Welcome to our dedicated page for Research Solutions SEC filings (Ticker: RSSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Research Solutions, Inc. (NASDAQ: RSSS) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into how Research Solutions reports its financial results, describes its vertical SaaS and AI business, and addresses governance and shareholder matters.
Research Solutions uses current reports on Form 8-K to announce events such as quarterly and annual financial results, preliminary earnings updates, and certain management or governance changes. For example, the company has filed 8-Ks to furnish press releases describing platform and transaction revenue, annual recurring revenue (ARR), gross margin trends, net income, and Adjusted EBITDA, as well as to disclose changes in executive roles.
The company’s proxy statement on Form DEF 14A outlines topics such as director elections, ratification of the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. It also provides information about the virtual format of the annual meeting, voting procedures, and certain aspects of corporate governance and executive pay.
On this page, users can review Research Solutions’ 10-K and 10-Q filings (when available), which contain more extensive discussions of its vertical SaaS and AI model, revenue sources from platform subscriptions and transactions, risk factors, and segment information. Investors can also examine Form 4 insider transaction reports and other ownership-related filings to understand how officers, directors, and significant shareholders transact in RSSS stock.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, helping readers navigate lengthy documents such as annual reports or complex 8-K disclosures. Real-time updates from EDGAR ensure that new Research Solutions filings appear promptly, while AI explanations can assist users in interpreting financial metrics, non-GAAP measures like Adjusted EBITDA, and governance-related proposals.
A director of Research Solutions, Inc. reported receiving an option to purchase 50,000 shares of the company’s common stock. The stock option was granted on 11/12/2025 with an exercise price of $3.07 per share and an expiration date of 11/11/2035. The option was reported as directly owned and carried a price of $0 at grant, indicating it was an award rather than a market purchase.
According to the vesting terms, one-third of the options vest on November 12, 2026, and one-twelfth of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested. This creates a multi‑year vesting schedule that ties the director’s potential ownership to ongoing service and future company performance.
Research Solutions, Inc. reported that one of its directors exercised stock options to acquire 75,000 shares of common stock on 11/12/2025 at an exercise price of $0.7 per share. Following this transaction, the director directly beneficially owns 484,608 shares of the company’s common stock.
On the same date, the director was granted a new option to purchase 50,000 shares of common stock at an exercise price of $3.07 per share, expiring on 11/11/2035. According to the vesting schedule, one third of these options vest on November 12, 2026 and one twelfth vest on the last day of each quarter beginning December 31, 2026 until fully vested, while the previously held option for 75,000 shares at $0.7 was fully exercised and now shows 0 remaining.
Research Solutions, Inc. (RSSS) director Form 4 reports an option exercise and share acquisition. On 11/17/2025, the reporting director exercised an option to purchase 150,000 shares of common stock at an exercise price of
Research Solutions, Inc. (RSSS)60,000 shares of common stock on 11/12/2025 at an exercise price of $3.07 per share. These stock options expire on 11/11/2035, giving the holder a long window to buy shares at that price if they choose.
The options vest over time. One-third of the grant vests on 11/12/2026, and the remaining two-thirds vest in equal installments on the last day of each quarter beginning 12/31/2026 until fully vested. Following this transaction, the reporting person directly holds 60,000 derivative securities (stock options) tied to Research Solutions common stock.
Research Solutions, Inc. (RSSS)November 12, 2025, the director was granted an option to purchase 50,000 shares of common stock at an exercise price of $3.07 per share, expiring on November 11, 2035. The option was acquired as a direct holding with no cash price for the derivative itself. The vesting schedule provides that one-third of the options vest on November 12, 2026, and one-twelfth vest on the last day of each quarter beginning December 31, 2026 until fully vested.
Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant to purchase 50,000 shares of common stock on 11/12/2025. The stock options have an exercise price of $3.07 per share and expire on 11/11/2035. According to the vesting schedule, one-third of the options vest on November 12, 2026, with the remaining options vesting in equal quarterly installments on the last day of each quarter beginning December 31, 2026 until fully vested. The options are held as direct ownership by the reporting person.
Research Solutions, Inc. reported a stronger quarter for the period ended September 30, 2025. Revenue rose to
Net income increased to
The company continued settling the Scite acquisition earnout: a first payment in August 2025 included
Research Solutions, Inc. reported stockholder voting results from its November 12, 2025 annual meeting. Of 32,821,783 shares entitled to vote, 24,873,088 were represented (75.78%).
Stockholders cast votes for six director nominees, with “For” votes ranging from 17,148,886 to 17,846,193. The appointment of Wipfli LLP as independent accountants for the year ending June 30, 2026 received 24,841,816 “For,” 20,420 “Against,” and 10,852 “Abstain.” The advisory vote on executive compensation received 17,844,026 “For,” 26,733 “Against,” 62,956 “Abstain,” and 6,939,373 broker non-votes. On say‑on‑pay frequency, votes were 17,832,593 for 1 year, 1,557 for 2 years, 78,131 for 3 years, and 21,434 abstentions.
William Nurthen, Chief Financial Officer and Secretary of Research Solutions, Inc. (RSSS), reported a transaction dated 09/19/2025 in which he surrendered 2,225 shares of the company’s common stock to the issuer to cover taxes on vested restricted stock at an effective price of $3.66 per share. After the surrender, he beneficially owned 378,382 shares. The filing is signed by Mr. Nurthen on 09/26/2025. The explanation states the share surrender was approved by the Compensation Committee.
FAQ
What is the current stock price of Research Solutions (RSSS)?
What is the market cap of Research Solutions (RSSS)?
